These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1588035)
1. Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. Collins DS; Findlay K; Harding CV J Immunol; 1992 Jun; 148(11):3336-41. PubMed ID: 1588035 [TBL] [Abstract][Full Text] [Related]
2. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. Harding CV; Collins DS; Kanagawa O; Unanue ER J Immunol; 1991 Nov; 147(9):2860-3. PubMed ID: 1918996 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. Rock KL; Clark K J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907 [TBL] [Abstract][Full Text] [Related]
4. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. Garg N; Nunes MP; Tarleton RL J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286 [TBL] [Abstract][Full Text] [Related]
5. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo. Ishioka GY; Colon S; Miles C; Grey HM; Chesnut RW J Immunol; 1989 Aug; 143(4):1094-100. PubMed ID: 2787356 [TBL] [Abstract][Full Text] [Related]
7. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. Lipford GB; Hoffman M; Wagner H; Heeg K J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422 [TBL] [Abstract][Full Text] [Related]
8. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes. Tremblay N; Fontaine P; Perreault C Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709 [TBL] [Abstract][Full Text] [Related]
9. Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways. Ke Y; McGraw CL; Hunter RL; Kapp JA Cell Immunol; 1997 Mar; 176(2):113-21. PubMed ID: 9073383 [TBL] [Abstract][Full Text] [Related]
10. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. Harding CV; Song R J Immunol; 1994 Dec; 153(11):4925-33. PubMed ID: 7963555 [TBL] [Abstract][Full Text] [Related]
11. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway. Martinez-Kinader B; Lipford GB; Wagner H; Heeg K Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131 [TBL] [Abstract][Full Text] [Related]
12. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity. De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380 [TBL] [Abstract][Full Text] [Related]
13. Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. Zhou F; Rouse BT; Huang L J Immunol; 1992 Sep; 149(5):1599-604. PubMed ID: 1387144 [TBL] [Abstract][Full Text] [Related]
14. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways. Singer A; Kruisbeek AM; Andrysiak PM J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. Maecker HT; Umetsu DT; DeKruyff RH; Levy S J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678 [TBL] [Abstract][Full Text] [Related]
16. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells. Ikehara Y; Shiuchi N; Kabata-Ikehara S; Nakanishi H; Yokoyama N; Takagi H; Nagata T; Koide Y; Kuzushima K; Takahashi T; Tsujimura K; Kojima N Cancer Lett; 2008 Feb; 260(1-2):137-45. PubMed ID: 18077084 [TBL] [Abstract][Full Text] [Related]
17. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen. Chen W; Carbone FR; McCluskey J J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698 [TBL] [Abstract][Full Text] [Related]
18. Epitope cleavage by Leishmania endopeptidase(s) limits the efficiency of the exogenous pathway of major histocompatibility complex class I-associated antigen presentation. Garcia MR; Graham S; Harris RA; Beverley SM; Kaye PM Eur J Immunol; 1997 Apr; 27(4):1005-13. PubMed ID: 9130657 [TBL] [Abstract][Full Text] [Related]
19. Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity. Bungener L; Huckriede A; de Mare A; de Vries-Idema J; Wilschut J; Daemen T Vaccine; 2005 Jan; 23(10):1232-41. PubMed ID: 15652665 [TBL] [Abstract][Full Text] [Related]
20. Investigation of antigen delivery route in vivo and imune-boosting effects mediated by pH-sensitive liposomes encapsulated with K(b)-restricted CTL epitope. Lee KY; Chun E; Seong BL Biochem Biophys Res Commun; 2002 Apr; 292(3):682-8. PubMed ID: 11922620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]